The top S&P 500 healthcare gainers and losers for the last week are as follows: Bio-Techne ( TECH) +22.58% AbbVie ( ABBV) +17.03% Charles River Laboratories International ( CRL) +16.62% Incyte ( INCY) ...
2don MSN
Health care roundup: Market talk
Find insight on Bayer, Merck and more in the latest Market Talks covering the health care sector.
In the latest large pharmaceutical industry deal, Covington, Fried Frank, Morgan Lewis and Sullivan & Cromwell are advising on a $14.2 billion transaction between Merck and German drug giant Bayer. In ...
Iambic AI forms drug discovery collaboration with Bayer and Merck partners with maternal health company Mae to support Black ...
Drug reviewers at the European Medicines Agency figured that Eli Lilly doesn't need a separate indication for Mounjaro’s use in sleep apnea. (European Union) In a flurry of decisions Friday, the ...
This week, Bayer announced first-quarter 2025 results. Novo Nordisk and GSK plc announced licensing deals with smaller biotechs. The FDA granted approval to Merck's drug, Welireg, for its third ...
German pharmaceutical company Bayer has agreed to acquire Whitehouse Station, N.J.-based Merck & Co.’s OTC consumer care business for $14.2 billion. In 2013, 70 percent of Merck’s OTC consumer care ...
Merck & Co has agreed to pay $100 million to settle hundreds of lawsuits accusing the U.S. drugmaker of downplaying serious health risks associated with its NuvaRing contraceptive device, Bloomberg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results